Ecopharmacology: an issue that needs urgent action
Abstract
Full Text:
PDFReferences
Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P. Implementing ecopharmacovigilance in practice: challenges and potential opportunities. Drug Safety. 2013;36(7):533-46.
Revannasiddaiah N, Kumar CA. India's progress towards ecopharmacovigilance. Drug Discov Ther. 2015;3(31):62-8.
Medhi B, Sewal RK. Ecopharmacovigilance: an issue urgently to be addressed. Indian J Pharmacol. 2012;44(5):547-9.
Srivastava B, Sinha AJ, Gaur S, Gaur S, Palaria U. Eco pharmaco vigilance: its importance and challenges. J Pharm Biomed Sci. 2014;3(3):81-7.
Boxall ABA. The environmental side effects of medication. EMBO Reports. 2004;5(12):1110-6.
Kϋmmerer K. Significance of antibiotics in the environment. J Antimicrob Chemother. 2003;52:5-7.
Lubick N. Drugs in the environment: do pharmaceutical take-back programs make a difference? Environ Health Perspect. 2010;118(5):A210-214.
Kϋmmerer K. The presence of pharmaceuticals in the environment due to human use: present knowledge and future challenges. J Environ Manage. 2009;90(8):2354-66.
WHO/DAP. Guidelines for Safe disposal of unwanted pharmaceuticals in and after emergencies. interagency guidelines. World Health Organization; 1999.